Patent · US Expired

Use of insulin and IGF-1

US5756463A · kind A · utility

2Cited by

3References

18Claims

0Family size

Assignee

Pharmacia & UpJohn AB · SE

Inventors

Vibeke Arrhenius-Nyberg · Järfälla, SE
Kjell Malmlof · Solna, SE
Anna Skottner · Ekerö, SE

Key dates

Filing date	Dec 18, 1996
Grant date	May 26, 1998
Priority date	—
Expiry date	Dec 18, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is disclosed for counteracting a decrease in nitrogen balance and counteracting a decrease in protein synthesis in an individual, comprising administering to the individual a combination of insulin and IGF-I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.